Pambansang Botika aims to lower medicine, vaccine costs
Pambansang Botika aims to lower medicine, vaccine costs

Revamping Healthcare The Evolution of Pambansang Botika Aims to Lower Medicine and Vaccine Costs
The Philippine Pharma Procurement Inc. (PPPI) has partnered with the Social Security System (SSS) to launch the Pambansang Botika at Bakuna para sa Mamamayan, a groundbreaking program designed to provide more affordable and accessible medicines and vaccines to communities across the Philippines.
During a soft opening held recently at the SSS office in Diliman, Quezon City, PPPI President and CEO Maria Blanca Kim Lokin emphasized the significance of this initiative. The establishment of Pambansang Botika is a crucial step towards realizing President Marcos Jr.'s vision of making quality medicines more accessible to the Filipino people, she said.
Building on the success of its predecessor, the revamped program extends the reach of the former Botika ng Bayan, which was previously available only in health centers and government hospitals. Lokin committed to opening more branches, particularly in underserved communities and remote areas. SSS President and CEO Robert Joseph de Claro praised the initiative, pledging to roll out similar establishments in SSS branches across the country.
PhilHealth Vice President Walter Bacareza welcomed the establishment of Pambansang Botika, revealing that his agency will be accrediting the PPPI program and linking it with their Yakap program. The Yakap program is an enhanced primary care benefit package designed to provide free consultations, laboratory tests, and medicines for all Filipinos to prevent, detect, and treat diseases early.
The launch of Pambansang Botika comes at a critical time when access to healthcare is more pressing than ever. A study by the Philippine Institute for Development Studies in June 2022 revealed that among surveyed hospitals, only 3 percent of local government unit hospitals, 55 percent of public and national hospitals, and 20 percent of private hospitals have complete essential drugs.
The PPPI's initiative aims to bridge this gap by providing more affordable and accessible medicines and vaccines. With the support of various agencies, pharmaceutical companies, and organizations like The Manila Times, Lokin expressed her gratitude for the efforts made towards making Pambansang Botika a success.
As the program continues to evolve, it is expected to have a significant impact on healthcare in the Philippines, particularly in underserved communities where access to quality medicines and vaccines is limited. By providing more affordable options, Pambansang Botika has the potential to improve health outcomes and reduce healthcare costs for Filipinos nationwide.